Keyphrases
Diabetes
100%
Type 1 Diabetes Mellitus (T1DM)
100%
Receptor Agonist
100%
Receptor Activation
100%
Adenosine Receptors
100%
Type I Diabetes
100%
A2A Receptor
100%
Streptozotocin
66%
Cyclophosphamide
66%
Non-obese Diabetic Mice
66%
Pancreas
33%
Autoimmune Disease
33%
Receptor Antagonist
33%
Inflammatory Cytokines
33%
Interleukin-12 (IL-12)
33%
Lymphocytes
33%
Amino
33%
Beneficial Effects
33%
Adenosine
33%
IB-MECA
33%
Immunomodulation
33%
Endotoxin
33%
Ethyl
33%
KO Mice
33%
Non-selective
33%
Therapeutic Target
33%
CD-1 Mice
33%
MIP-1b
33%
Induced Cell Death
33%
Chloro
33%
A1 Receptor
33%
T Helper 1
33%
Phenoxy
33%
Adenosine Receptor Ligands
33%
Adenosine Receptor Agonists
33%
CGS21680
33%
Cyanophenyl
33%
A2B Receptor
33%
A3 Receptor
33%
Diabetes Development
33%
N6-Cyclopentyladenosine
33%
Dioxo
33%
Acetamide
33%
Anti-CD3
33%
Splenic Cells
33%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor Agonist
100%
Insulin Dependent Diabetes Mellitus
100%
Adenosine Receptor
100%
Receptor
66%
Cytokine
66%
Streptozotocin
66%
Cyclophosphamide
66%
Nonobese Diabetic Mouse
66%
Autoimmune Disease
33%
Receptor Antagonist
33%
Knockout Mouse
33%
Tumor Necrosis Factor
33%
Piclidenoson
33%
Adenosine
33%
Immunomodulation
33%
Endotoxin
33%
Adenosine Receptor Stimulating Agent
33%
Adenosine Receptor Ligands
33%
2 [4 (2 Carboxyethyl)phenethylamino]adenosine 5' (N Ethylcarboxamide)
33%
N (4 Cyanophenyl) 2 [4 (2,3,6,7 Tetrahydro 2,6 Dioxo 1,3 Dipropyl 1h Purin 8 Yl)phenoxy]acetamide
33%
2 Chloro 6 N Cyclopentyladenosine
33%
CD-1 Mouse
33%
CD3 Antigen
33%
Medicine and Dentistry
Receptor
100%
Insulin Dependent Diabetes Mellitus
100%
Adenosine Receptor
100%
Diabetes
80%
Diabetes Mellitus
40%
Cytokine
40%
Streptozocin
40%
Low Drug Dose
40%
Cyclophosphamide
40%
In Vitro
20%
Endotoxin
20%
Receptor Antagonist
20%
Immunomodulation
20%
Tumor Necrosis Factor
20%
Cell Death
20%
Autoimmune Disease
20%
Adenosine Receptor Ligands
20%
N (4 Cyanophenyl) 2 [4 (2,3,6,7 Tetrahydro 2,6 Dioxo 1,3 Dipropyl 1h Purin 8 Yl)phenoxy]acetamide
20%
2 Chloro 6 N Cyclopentyladenosine
20%
Piclidenoson
20%
CGS-21680
20%
Adenosine
20%
Adenosine Receptor Agonist
20%
CD3 Antigen
20%
Lymphocyte
20%
Immunology and Microbiology
Agonist
100%
Low Drug Dose
50%
Cyclophosphamide
50%
Nonobese Diabetic Mouse
50%
Pancreas
25%
Knockout Mouse
25%
Proinflammatory Cytokine
25%
Cytokine
25%
Cell Death
25%
Tumor Necrosis Factor
25%
Autoimmune Disease
25%
Immunomodulation
25%
CD-1 Mouse
25%
Splenocyte
25%
Lymphocyte
25%
CD3 Antigen
25%